Cargando…
Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer
Esophageal cancer is the seventh most common cancer worldwide and continues to have a poor prognosis. Starting with the development of immune checkpoint inhibitors for patients with metastatic melanoma, many clinical trials have been conducted to evaluate the efficacy and safety of immune checkpoint...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538995/ https://www.ncbi.nlm.nih.gov/pubmed/36047845 http://dx.doi.org/10.1093/jjco/hyac138 |